Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SOLRØD ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.4% 3.4% 2.2% 2.4% 2.2% 3.0% 7.6% 7.4%   Credit score (0-100)   66 55 66 62 65 56 32 33   Credit rating   BBB BBB BBB BBB BBB BBB BB BBB   Credit limit (kDKK)   0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,041 910 1,130 1,173 1,194 1,044 0.0 0.0   EBITDA   125 40.6 218 212 162 72.4 0.0 0.0   EBIT   57.5 -26.9 151 144 82.5 -6.3 0.0 0.0   Pre-tax profit (PTP)   88.1 5.4 186.1 178.4 115.3 39.9 0.0 0.0   Net earnings   56.4 -9.1 131.7 125.4 76.7 18.9 0.0 0.0   Pre-tax profit without non-rec. items   88.1 5.4 186 178 115 39.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   30.5 21.8 13.1 4.4 82.8 62.9 0.0 0.0   Shareholders equity total   1,352 1,343 1,475 1,600 1,677 1,696 1,571 1,571   Interest-bearing liabilities   0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,492 1,452 1,688 1,773 1,789 1,921 1,571 1,571   Net Debt   -81.3 -58.2 -337 -449 -213 -331 -1,453 -1,453     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,041 910 1,130 1,173 1,194 1,044 0.0 0.0   Gross profit growth   -1.3% -12.6% 24.2% 3.8% 1.8% -12.6% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,492 1,452 1,688 1,773 1,789 1,921 1,571 1,571   Balance sheet change%   -1.4% -2.7% 16.2% 5.0% 0.9% 7.4% -18.2% 0.0%   Added value   124.9 40.6 218.3 211.7 149.9 72.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -135 -135 -135 -135 -60 -157 -63 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.5% -3.0% 13.3% 12.3% 6.9% -0.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.2% 0.6% 11.9% 10.5% 6.9% 2.4% 0.0% 0.0%   ROI %   6.8% 0.7% 13.2% 11.6% 7.5% 2.6% 0.0% 0.0%   ROE %   4.3% -0.7% 9.3% 8.2% 4.7% 1.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   90.6% 92.5% 87.4% 90.3% 93.7% 88.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -65.0% -143.2% -154.4% -212.0% -131.4% -456.9% 0.0% 0.0%   Gearing %   0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.1% 553.4% 221.4% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   7.5 9.9 7.1 11.1 15.1 8.0 0.0 0.0   Current Ratio   7.5 9.9 7.1 11.1 15.1 8.0 0.0 0.0   Cash and cash equivalent   81.3 59.4 337.0 448.9 213.1 330.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   910.5 968.8 1,153.9 1,360.0 1,392.9 1,490.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   62 20 109 106 75 36 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   62 20 109 106 81 36 0 0   EBIT / employee   29 -13 75 72 41 -3 0 0   Net earnings / employee   28 -5 66 63 38 9 0 0